These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23943316)

  • 1. High dose deferoxamine in intracerebral hemorrhage (HI-DEF) trial: rationale, design, and methods.
    Yeatts SD; Palesch YY; Moy CS; Selim M
    Neurocrit Care; 2013 Oct; 19(2):257-66. PubMed ID: 23943316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and tolerability of deferoxamine mesylate in patients with acute intracerebral hemorrhage.
    Selim M; Yeatts S; Goldstein JN; Gomes J; Greenberg S; Morgenstern LB; Schlaug G; Torbey M; Waldman B; Xi G; Palesch Y;
    Stroke; 2011 Nov; 42(11):3067-74. PubMed ID: 21868742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trial.
    Selim M; Foster LD; Moy CS; Xi G; Hill MD; Morgenstern LB; Greenberg SM; James ML; Singh V; Clark WM; Norton C; Palesch YY; Yeatts SD;
    Lancet Neurol; 2019 May; 18(5):428-438. PubMed ID: 30898550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer's Disease, Parkinson's Disease, and Intracerebral Hemorrhage.
    Farr AC; Xiong MP
    Mol Pharm; 2021 Feb; 18(2):593-609. PubMed ID: 32926630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Deferoxamine on Trajectory of Recovery After Intracerebral Hemorrhage: A Post Hoc Analysis of the i-DEF Trial.
    Foster L; Robinson L; Yeatts SD; Conwit RA; Shehadah A; Lioutas V; Selim M;
    Stroke; 2022 Jul; 53(7):2204-2210. PubMed ID: 35306827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tranexamic acid to improve functional status in adults with spontaneous intracerebral haemorrhage: the TICH-2 RCT.
    Sprigg N; Flaherty K; Appleton JP; Al-Shahi Salman R; Bereczki D; Beridze M; Ciccone A; Collins R; Dineen RA; Duley L; Egea-Guerrero JJ; England TJ; Karlinski M; Krishnan K; Laska AC; Law ZK; Ovesen C; Ozturk S; Pocock SJ; Roberts I; Robinson TG; Roffe C; Peters N; Scutt P; Thanabalan J; Werring D; Whynes D; Woodhouse L; Bath PM
    Health Technol Assess; 2019 Jul; 23(35):1-48. PubMed ID: 31322116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Brain edema after intracerebral hemorrhage in rats: the role of iron overload and aquaporin 4.
    Qing WG; Dong YQ; Ping TQ; Lai LG; Fang LD; Min HW; Xia L; Heng PY
    J Neurosurg; 2009 Mar; 110(3):462-8. PubMed ID: 19025353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermo-sensitive keratin hydrogel against iron-induced brain injury after experimental intracerebral hemorrhage.
    Zhu Q; Gong Y; Guo T; Deng J; Ji J; Wang B; Hao S
    Int J Pharm; 2019 Jul; 566():342-351. PubMed ID: 31158456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale and Design of a Randomized, Double-Blind Trial Evaluating the Efficacy of Tranexamic Acid on Hematoma Expansion and Peri-hematomal Edema in Patients with Spontaneous Intracerebral Hemorrhage within 4.5 h after Symptom Onset: The THE-ICH Trial Protocol.
    Jiang C; Wang J; Wang J; Zhang J;
    J Stroke Cerebrovasc Dis; 2020 Oct; 29(10):105136. PubMed ID: 32912508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spot sign and tranexamic acid on preventing ICH growth--AUStralasia Trial (STOP-AUST): protocol of a phase II randomized, placebo-controlled, double-blind, multicenter trial.
    Meretoja A; Churilov L; Campbell BC; Aviv RI; Yassi N; Barras C; Mitchell P; Yan B; Nandurkar H; Bladin C; Wijeratne T; Spratt NJ; Jannes J; Sturm J; Rupasinghe J; Zavala J; Lee A; Kleinig T; Markus R; Delcourt C; Mahant N; Parsons MW; Levi C; Anderson CS; Donnan GA; Davis SM
    Int J Stroke; 2014 Jun; 9(4):519-24. PubMed ID: 23981692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical effect of deferoxamine mesylate on edema after intracerebral hemorrhage.
    Yu Y; Zhao W; Zhu C; Kong Z; Xu Y; Liu G; Gao X
    PLoS One; 2015; 10(4):e0122371. PubMed ID: 25875777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Failure of deferoxamine, an iron chelator, to improve outcome after collagenase-induced intracerebral hemorrhage in rats.
    Warkentin LM; Auriat AM; Wowk S; Colbourne F
    Brain Res; 2010 Jan; 1309():95-103. PubMed ID: 19879860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deferoxamine therapy for intracerebral hemorrhage.
    Hua Y; Keep RF; Hoff JT; Xi G
    Acta Neurochir Suppl; 2008; 105():3-6. PubMed ID: 19066072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deferoxamine reduces CSF free iron levels following intracerebral hemorrhage.
    Wan S; Hua Y; Keep RF; Hoff JT; Xi G
    Acta Neurochir Suppl; 2006; 96():199-202. PubMed ID: 16671454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload.
    Piga A; Galanello R; Forni GL; Cappellini MD; Origa R; Zappu A; Donato G; Bordone E; Lavagetto A; Zanaboni L; Sechaud R; Hewson N; Ford JM; Opitz H; Alberti D
    Haematologica; 2006 Jul; 91(7):873-80. PubMed ID: 16818273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deferoxamine reduces neuronal death and hematoma lysis after intracerebral hemorrhage in aged rats.
    Hatakeyama T; Okauchi M; Hua Y; Keep RF; Xi G
    Transl Stroke Res; 2013 Oct; 4(5):546-53. PubMed ID: 24187595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fingolimod for the treatment of intracerebral hemorrhage: a 2-arm proof-of-concept study.
    Fu Y; Hao J; Zhang N; Ren L; Sun N; Li YJ; Yan Y; Huang D; Yu C; Shi FD
    JAMA Neurol; 2014 Sep; 71(9):1092-101. PubMed ID: 25003359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deferoxamine in intracerebral hemorrhage: Systematic review and meta-analysis.
    Sun T; Zhao YY; Xiao QX; Wu M; Luo MY
    Clin Neurol Neurosurg; 2023 Apr; 227():107634. PubMed ID: 36857886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and efficacy of herbal medicine for acute intracerebral hemorrhage (CRRICH): a multicentre randomised controlled trial.
    Zeng L; Tang G; Wang J; Zhong J; Xia Z; Li J; Chen G; Zhang Y; Luo S; Huang G; Zhao Q; Wan Y; Chen C; Zhu K; Qiao H; Wang J; Huang T; Liu X; Zhang Q; Lin R; Li H; Gong B; Chen X; Zhou Y; Wen Z; Guo J
    BMJ Open; 2019 May; 9(5):e024932. PubMed ID: 31076468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of Deferoxamine Mesylate on Hematoma and Perihematoma Edema after Traumatic Intracerebral Hemorrhage.
    Yu J; Yuan Q; Sun YR; Wu X; Du ZY; Li ZQ; Wu XH; Zhou LF; Wu G; Hu J
    J Neurotrauma; 2017 Oct; 34(19):2753-2759. PubMed ID: 28462672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.